MPGSX
Price
$11.49
Change
+$0.19 (+1.68%)
Updated
Jan 22 closing price
Net Assets
203.55M
RGACX
Price
$75.80
Change
+$0.53 (+0.70%)
Updated
Jan 22 closing price
Net Assets
310.06B
Ad is loading...

MPGSX vs RGACX

Header iconMPGSX vs RGACX Comparison
Open Charts MPGSX vs RGACXBanner chart's image
MassMutual Disciplined Gr R5
Price$11.49
Change+$0.19 (+1.68%)
VolumeN/A
Net Assets203.55M
American Funds Growth Fund of Amer R3
Price$75.80
Change+$0.53 (+0.70%)
VolumeN/A
Net Assets310.06B
MPGSX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MPGSX vs. RGACX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MPGSX is a Hold and RGACX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 310B vs. MPGSX (204M). RGACX pays higher dividends than MPGSX: RGACX (0.25) vs MPGSX (0.01). MPGSX was incepted earlier than RGACX: MPGSX (20 years) vs RGACX (23 years). MPGSX is a more actively managed with annual turnover of: 64.00 vs. RGACX (31.00). MPGSX has a lower initial minimum investment than RGACX: MPGSX (0) vs RGACX (250). RGACX annual gain was more profitable for investors over the last year : 20.97 vs. MPGSX (13.11). RGACX return over 5 years is better than : 45.22 vs. MPGSX (2.50).
MPGSXRGACXMPGSX / RGACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years23 years-
Gain YTD2.0784.55646%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets204M310B0%
Annual Yield % from dividends0.010.253%
Returns for 1 year13.1120.9763%
Returns for 3 years17.2419.1090%
Returns for 5 years2.5045.226%
Returns for 10 years1.4278.892%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AXSM96.184.25
+4.62%
Axsome Therapeutics
IR94.082.20
+2.39%
Ingersoll Rand
COLL33.19-0.16
-0.48%
Collegium Pharmaceutical
VTVT13.97-0.09
-0.60%
vTv Therapeutics
DSGN4.87-0.19
-3.75%
Design Therapeutics